Literature DB >> 20442137

A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions.

Tao Yu1, Zhongyou Li, Zhengping Jia, Steven J Clapcote, Chunhong Liu, Shaomin Li, Suhail Asrar, Annie Pao, Rongqing Chen, Ni Fan, Sandra Carattini-Rivera, Allison R Bechard, Shoshana Spring, R Mark Henkelman, George Stoica, Sei-Ichi Matsui, Norma J Nowak, John C Roder, Chu Chen, Allan Bradley, Y Eugene Yu.   

Abstract

Down syndrome (DS) is caused by the presence of an extra copy of human chromosome 21 (Hsa21) and is the most common genetic cause for developmental cognitive disability. The regions on Hsa21 are syntenically conserved with three regions located on mouse chromosome 10 (Mmu10), Mmu16 and Mmu17. In this report, we describe a new mouse model for DS that carries duplications spanning the entire Hsa21 syntenic regions on all three mouse chromosomes. This mouse mutant exhibits DS-related neurological defects, including impaired cognitive behaviors, reduced hippocampal long-term potentiation and hydrocephalus. These results suggest that when all the mouse orthologs of the Hsa21 genes are triplicated, an abnormal cognitively relevant phenotype is the final outcome of the elevated expressions of these orthologs as well as all the possible functional interactions among themselves and/or with other mouse genes. Because of its desirable genotype and phenotype, this mutant may have the potential to serve as one of the reference models for further understanding the developmental cognitive disability associated with DS and may also be used for developing novel therapeutic interventions for this clinical manifestation of the disorder.

Entities:  

Mesh:

Year:  2010        PMID: 20442137      PMCID: PMC2893810          DOI: 10.1093/hmg/ddq179

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  77 in total

1.  Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-01-06       Impact factor: 17.586

2.  Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Authors:  Ahmad Salehi; Jean-Dominique Delcroix; Pavel V Belichenko; Ke Zhan; Chengbiao Wu; Janice S Valletta; Ryoko Takimoto-Kimura; Alexander M Kleschevnikov; Kumar Sambamurti; Peter P Chung; Weiming Xia; Angela Villar; William A Campbell; Laura Shapiro Kulnane; Ralph A Nixon; Bruce T Lamb; Charles J Epstein; Gorazd B Stokin; Lawrence S B Goldstein; William C Mobley
Journal:  Neuron       Date:  2006-07-06       Impact factor: 17.173

Review 3.  TRPM2.

Authors:  J Eisfeld; A Lückhoff
Journal:  Handb Exp Pharmacol       Date:  2007

4.  Effects of the rd1 mutation and host strain on hippocampal learning in mice.

Authors:  Steven J Clapcote; Noah L Lazar; Allison R Bechard; John C Roder
Journal:  Behav Genet       Date:  2005-09       Impact factor: 2.805

5.  Down syndrome with congenital hydrocephalus: case report.

Authors:  Cassiano Mateus Forcelini; Adroaldo Baseggio Mallmann; Paulo Sérgio Crusius; Cláudio Albano Seibert; Marcelo Ughini Crusius; Denise Isabel Zandoná; Charles Carazzo; Cassiano Ughini Crusius; Eduardo Goellner; Jean Ragnini; Luciano Bambini Manzato; Gustavo Winkelmann; Aline Vieira Lima; Manfred Georg Bauermann
Journal:  Arq Neuropsiquiatr       Date:  2006-09       Impact factor: 1.420

6.  DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects.

Authors:  Kyoung-Jin Ahn; Hey Kyeong Jeong; Han-Saem Choi; Soo-Ryoon Ryoo; Yeon Ju Kim; Jun-Seo Goo; Se-Young Choi; Jung-Soo Han; Ilho Ha; Woo-Joo Song
Journal:  Neurobiol Dis       Date:  2006-02-07       Impact factor: 5.996

7.  Down syndrome mouse models are looking up.

Authors:  Roger H Reeves
Journal:  Trends Mol Med       Date:  2006-05-04       Impact factor: 11.951

8.  BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.

Authors:  Kouhei Nishitomi; Gaku Sakaguchi; Yuko Horikoshi; Audrey J Gray; Masahiro Maeda; Chiho Hirata-Fukae; Amanda G Becker; Motoko Hosono; Isako Sakaguchi; S Sakura Minami; Yoshihiro Nakajima; Hui-Fang Li; Chie Takeyama; Tsuyoshi Kihara; Akinobu Ota; Philip C Wong; Paul S Aisen; Akira Kato; Noriaki Kinoshita; Yasuji Matsuoka
Journal:  J Neurochem       Date:  2006-11-02       Impact factor: 5.372

9.  NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.

Authors:  Joseph R Arron; Monte M Winslow; Alberto Polleri; Ching-Pin Chang; Hai Wu; Xin Gao; Joel R Neilson; Lei Chen; Jeremy J Heit; Seung K Kim; Nobuyuki Yamasaki; Tsuyoshi Miyakawa; Uta Francke; Isabella A Graef; Gerald R Crabtree
Journal:  Nature       Date:  2006-03-22       Impact factor: 49.962

10.  An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes.

Authors:  Aideen O'Doherty; Sandra Ruf; Claire Mulligan; Victoria Hildreth; Mick L Errington; Sam Cooke; Abdul Sesay; Sonie Modino; Lesley Vanes; Diana Hernandez; Jacqueline M Linehan; Paul T Sharpe; Sebastian Brandner; Timothy V P Bliss; Deborah J Henderson; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  Science       Date:  2005-09-23       Impact factor: 63.714

View more
  109 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

Review 2.  Down syndrome: from understanding the neurobiology to therapy.

Authors:  Katheleen Gardiner; Yann Herault; Ira T Lott; Stylianos E Antonarakis; Roger H Reeves; Mara Dierssen
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

3.  Construction and phenotypic analysis of mice carrying a duplication of the major histocompatibility class I (MHC-I) locus.

Authors:  Olga Ermakova; Ekaterina Salimova; Lukasz Piszczek; Cornelius Gross
Journal:  Mamm Genome       Date:  2012-07-07       Impact factor: 2.957

4.  The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.

Authors:  Ahmad Salehi; J Wesson Ashford; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

5.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

6.  Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Authors:  Verónica Vidal; Susana García-Cerro; Paula Martínez; Andrea Corrales; Sara Lantigua; Rebeca Vidal; Noemí Rueda; Laurence Ozmen; Maria-Clemencia Hernández; Carmen Martínez-Cué
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 7.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

8.  Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions.

Authors:  Xiaolu Sturgeon; Katheleen J Gardiner
Journal:  Mamm Genome       Date:  2011-03-13       Impact factor: 2.957

Review 9.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

10.  Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Authors:  Li Zhang; Kai Meng; Xiaoling Jiang; Chunhong Liu; Annie Pao; Pavel V Belichenko; Alexander M Kleschevnikov; Sheena Josselyn; Ping Liang; Ping Ye; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2013-09-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.